PT985666E - Compostos de indole substituidos como inibidores de cox-2 - Google Patents
Compostos de indole substituidos como inibidores de cox-2Info
- Publication number
- PT985666E PT985666E PT99306991T PT99306991T PT985666E PT 985666 E PT985666 E PT 985666E PT 99306991 T PT99306991 T PT 99306991T PT 99306991 T PT99306991 T PT 99306991T PT 985666 E PT985666 E PT 985666E
- Authority
- PT
- Portugal
- Prior art keywords
- alkyl
- optionally substituted
- halo
- phenyl
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB9801382 | 1998-09-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT985666E true PT985666E (pt) | 2004-03-31 |
Family
ID=11004747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99306991T PT985666E (pt) | 1998-09-07 | 1999-09-03 | Compostos de indole substituidos como inibidores de cox-2 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6277878B1 (pt) |
| EP (1) | EP0985666B1 (pt) |
| JP (1) | JP3256526B2 (pt) |
| AT (1) | ATE253557T1 (pt) |
| BR (1) | BR9905586A (pt) |
| CA (1) | CA2281426C (pt) |
| DE (1) | DE69912552T2 (pt) |
| DK (1) | DK0985666T3 (pt) |
| ES (1) | ES2209342T3 (pt) |
| PT (1) | PT985666E (pt) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040072889A1 (en) * | 1997-04-21 | 2004-04-15 | Pharmacia Corporation | Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
| AP9801302A0 (en) * | 1997-07-23 | 2000-01-23 | Pfizer | Indole compounds as anti-inflammatory/analgesic agents.. |
| US20040053900A1 (en) * | 1998-12-23 | 2004-03-18 | Pharmacia Corporation | Method of using a COX-2 inhibitor and an aromatase inhibitor as a combination therapy |
| CZ20012320A3 (cs) * | 1998-12-23 | 2002-10-16 | G. D. Searle & Co. | Léčivo s obsahem inhibitoru cyklooxygenázy-2 a jednoho nebo více antineoplastických činidel pro kombinační terapii při léčení neoplasie |
| US6649645B1 (en) | 1998-12-23 | 2003-11-18 | Pharmacia Corporation | Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia |
| US20030119895A1 (en) * | 1998-12-23 | 2003-06-26 | Pharmacia Corporation | Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia |
| US20030013739A1 (en) * | 1998-12-23 | 2003-01-16 | Pharmacia Corporation | Methods of using a combination of cyclooxygenase-2 selective inhibitors and thalidomide for the treatment of neoplasia |
| US20030203956A1 (en) * | 1998-12-23 | 2003-10-30 | Masterrer Jaime L. | Method of using a cyclooxygenase-2 inhibitor and one or more ornithine decarboxylase inhibitors as a combination therapy in the treatment of neoplasia |
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| US20020103141A1 (en) * | 1998-12-23 | 2002-08-01 | Mckearn John P. | Antiangiogenic combination therapy for the treatment of cancer |
| GB2350112A (en) * | 1999-05-17 | 2000-11-22 | Bayer Ag | Pharmaceutically active cycloalkyl ketones |
| PE20021017A1 (es) | 2001-04-03 | 2002-11-24 | Pharmacia Corp | Composicion parenteral reconstituible |
| DK1465634T3 (da) | 2001-12-12 | 2015-01-26 | Us Government | Fremgangsmåde til anvendelse af adenosinreceptorinhibitorer til at forstærke immunrespons og inflammation |
| CA2481934A1 (en) * | 2002-04-18 | 2003-10-30 | Pharmacia Corporation | Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease |
| BR0309337A (pt) * | 2002-04-18 | 2005-02-15 | Pharmacia Corp | Monoterapia para o tratamento de doença de parkinson com inibidores de ciclooxigenase-2 (cox2) |
| EP1638612A4 (en) * | 2003-06-25 | 2010-09-29 | Univ Vanderbilt | COX-2-MADE DISPLAY AGENTS |
| EP1646624A1 (en) * | 2003-07-09 | 2006-04-19 | Biolipox AB | Indoles useful in the treatment of inflammation |
| CN101031289A (zh) * | 2004-04-26 | 2007-09-05 | 范德比尔特大学 | 作为具有降低胃肠毒性的治疗剂的吲哚乙酸和茚乙酸衍生物 |
| AU2006204523A1 (en) * | 2005-01-04 | 2006-07-13 | Novartis Ag | X-ray structure of human FPPS and use for selecting FPPS binding compounds |
| EA200701504A1 (ru) | 2005-01-19 | 2008-02-28 | Биолипокс Аб | Индолы, пригодные для лечения воспалений |
| CA2657691A1 (en) * | 2006-06-19 | 2007-12-27 | Vanderbilt University | Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| EP3078374B1 (en) | 2011-10-17 | 2019-06-19 | Vanderbilt University | Indomethacin analogs for the treatment of castrate-resistant prostate cancer |
| US9808443B1 (en) | 2016-11-28 | 2017-11-07 | King Saud University | Cyclooxygenase inhibitors |
| IL305573A (en) | 2021-03-15 | 2023-10-01 | Saul Yedgar | Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5189054A (en) * | 1990-11-02 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | 3-amidoindolyl derivatives and pharmaceutical compositions thereof |
| US5145845A (en) * | 1991-05-14 | 1992-09-08 | Warner-Lambert Co. | Substituted 2-carboxylindoles having pharmaceutical activity |
| US5436265A (en) * | 1993-11-12 | 1995-07-25 | Merck Frosst Canada, Inc. | 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents |
| US5510368A (en) * | 1995-05-22 | 1996-04-23 | Merck Frosst Canada, Inc. | N-benzyl-3-indoleacetic acids as antiinflammatory drugs |
| WO1997013767A1 (de) * | 1995-10-09 | 1997-04-17 | Chemisch Pharmazeutische Forschungsgesellschaft Mbh | Heterocyclisch substituierte 1-indolcarboxamide als cyclooxygenase-2 inhibitoren |
-
1999
- 1999-08-26 US US09/383,353 patent/US6277878B1/en not_active Expired - Fee Related
- 1999-09-01 JP JP24758399A patent/JP3256526B2/ja not_active Expired - Fee Related
- 1999-09-03 ES ES99306991T patent/ES2209342T3/es not_active Expired - Lifetime
- 1999-09-03 DK DK99306991T patent/DK0985666T3/da active
- 1999-09-03 CA CA002281426A patent/CA2281426C/en not_active Expired - Fee Related
- 1999-09-03 EP EP99306991A patent/EP0985666B1/en not_active Expired - Lifetime
- 1999-09-03 PT PT99306991T patent/PT985666E/pt unknown
- 1999-09-03 DE DE69912552T patent/DE69912552T2/de not_active Expired - Fee Related
- 1999-09-03 AT AT99306991T patent/ATE253557T1/de not_active IP Right Cessation
- 1999-09-06 BR BR9905586-4A patent/BR9905586A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE253557T1 (de) | 2003-11-15 |
| JP2000086630A (ja) | 2000-03-28 |
| EP0985666B1 (en) | 2003-11-05 |
| DE69912552T2 (de) | 2004-09-23 |
| US6277878B1 (en) | 2001-08-21 |
| DE69912552D1 (de) | 2003-12-11 |
| CA2281426C (en) | 2004-12-28 |
| CA2281426A1 (en) | 2000-03-07 |
| JP3256526B2 (ja) | 2002-02-12 |
| DK0985666T3 (da) | 2004-03-15 |
| ES2209342T3 (es) | 2004-06-16 |
| EP0985666A1 (en) | 2000-03-15 |
| BR9905586A (pt) | 2000-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT985666E (pt) | Compostos de indole substituidos como inibidores de cox-2 | |
| NO882036D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske ketoner. | |
| YU41600A (sh) | 2,3-substituisana indol jedinjenja kao cox-2 inhibitori | |
| PT1065204E (pt) | Compostos de carbonil-indole biciclicos como agentes anti-inflamatorios/analgesicos e como inibidores de cox-2 | |
| BRPI9908319B8 (pt) | composto amino cíclico, composição farmacêutica, medicamento contendo um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo, e, uso de um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo. | |
| DK0976748T3 (da) | Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet | |
| CY1108367T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| MX9306831A (es) | Nuevos compuestos heterociclicos. | |
| PT784054E (pt) | Derivados de tetraidroquinoxalinadiona 1,2,3,4 e sua utilizacao como antagonistas do receptor glutamato | |
| BR9706241A (pt) | Composto de benzimidazol | |
| DE60101137D1 (de) | N-Benzensulfonyl-L-Prolin Derivate und deren Verwendung als Bradykinin Antagonisten | |
| BR0006371A (pt) | Compostos de 1,4-dihidropiridina substituìdos com heteroarilas de 5 membros como antagonistas de bradicinina | |
| ES2161916T3 (es) | Derivados de la tiazolidinona o de la oxazolidinona para el tratamiento de la angina de pecho y composiciones que las contienen como ingrediente activo. | |
| DE60203844D1 (de) | Verwendung von Hydantoin und seinen Derivaten gegen Hypalbuminämie | |
| EP1252891A4 (en) | MEDICINES FOR THE TREATMENT AND PREVENTION OF HEPATIC CONDITIONS, BASED ON DIAMINOTRIFLUOROMETHYLPYRIDINE DERIVATIVES | |
| BR0002935A (pt) | Compostos tetrazolilalquil-indol como agentes antiinflamatórios e analgésicos | |
| PL304334A1 (en) | Pharmaceutical composition of gastric protective action, including antiulceric one and method of treating diseases of gastrointestinal tract | |
| TH58670B (th) | อนุพันธ์ 2-อะมิโน-3-(แอลคิล)-พิริมิโดน |